With New Rare Blood Clot Warning, J&J COVID-19 Vaccine Rollout Resumes In EU
Countries May Impose Age Restrictions
Executive Summary
Similarities to AstraZeneca blood clots are clear, but more research needed before any ‘class effect’ conclusions can be drawn.